These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2718099)

  • 1. Long-term blockade of the dopamine uptake complex by metaphit, an isothiocyanate derivative of phencyclidine.
    Zimányi I; Jacobson AE; Rice KC; Lajtha A; Reith ME
    Synapse; 1989; 3(3):239-45. PubMed ID: 2718099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metaphit on dopaminergic neurotransmission in rat striatal slices: involvement of the dopamine transporter and voltage-dependent sodium channel.
    Reith ME; Jacobson AE; Rice KC; Benuck M; Zimanyi I
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1188-96. PubMed ID: 1662274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter.
    Schweri MM; Thurkauf A; Mattson MV; Rice KC
    J Pharmacol Exp Ther; 1992 Jun; 261(3):936-42. PubMed ID: 1602399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metaphit prevents locomotor activation induced by various psychostimulants and interferes with the dopaminergic system in mice.
    Sershen H; Berger P; Jacobson AE; Rice KC; Reith ME
    Neuropharmacology; 1988 Jan; 27(1):23-30. PubMed ID: 3352864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metaphit inhibits dopamine transport and binding of [3H]methylphenidate, a proposed marker for the dopamine transport complex.
    Schweri MM; Jacobson AE; Lessor RA; Rice KC
    Life Sci; 1989; 45(18):1689-98. PubMed ID: 2586226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
    J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D; Duterte-Boucher D; Leroux-Nicollet I; Naudon L; Costentin J
    J Pharmacol Exp Ther; 1996 Jul; 278(1):330-7. PubMed ID: 8764367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
    Reith ME; Selmeci G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.
    Aloyo VJ; Ruffin JS; Pazdalski PS; Kirifides AL; Harvey JA
    J Pharmacol Exp Ther; 1995 Apr; 273(1):435-44. PubMed ID: 7714799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
    Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
    Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaphit irreversibly inhibits [3H]threo-(+/-)-methylphenidate binding to rat striatal tissue.
    Schweri MM; Jacobson AE; Lessor RA; Rice KC
    J Neurochem; 1987 Jan; 48(1):102-5. PubMed ID: 3794693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaphit, a proposed phencyclidine receptor acylator: disruption of mouse motor behavior and absence of PCP antagonist activity.
    Domino EF; Gole D; Koek W
    J Pharmacol Exp Ther; 1987 Oct; 243(1):95-100. PubMed ID: 2822909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum.
    Gracz LM; Madras BK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1224-34. PubMed ID: 7791095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.
    Dersch CM; Akunne HC; Partilla JS; Char GU; de Costa BR; Rice KC; Carroll FI; Rothman RB
    Neurochem Res; 1994 Feb; 19(2):201-8. PubMed ID: 8183430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.